|
|
|
| Right-sized for biotech success | It’s not the size of your company. It’s the size of your passion and your dedication to improving patients’ lives that IQVIA Biotech is uniquely built to serve. There is nothing bigger to us than your success. We’ve got you. |
|
|
|
| Defying Industry Setbacks, MindMed Advances Psychedelic To Phase 3 | From The Editor | By Dan Schell, chief editor, Clinical Leader | Despite the psychedelics industry reeling from Lykos’ recent failed FDA hearing, MindMed is riding high after a positive End-of-Phase 2 (EOP2) meeting with the regulator that has set up the small biopharma for a Phase 3 trial of its LSD-based treatment for generalized anxiety disorder (GAD). |
|
|
|
| 4 Ways Concomitant Medications Can Complicate Your Trial | Article | Oracle Life Sciences | Concomitant medications (con-meds) significantly influence clinical trials, affecting duration, costs, and participant safety. However, they are often inadequately tracked and analyzed in studies. |
|
|
| Q&A With Novartis And IQVIA Study Start-Up Leaders | Q&A | Origin: Novartis, IQVIA Technologies | The industry is measuring longer cycle times between protocol approval and site activation. Experts from Novartis and IQVIA share creative solutions to combat this trend and accelerate trial timelines. |
|
|
|
|
|
| Patient recruitment and retention is a multi-faceted, critical component of clinical trial success. Diversity, timeliness, enrollment, reimbursement, logistics, engagement – where do you start? On August 7th, hear from industry-leading suppliers ready to answer that question – and help solve your specific recruitment and retention challenges. The Clinical Leader Solutions Expo brings you its latest virtual event to help facilitate partnerships that bring life-saving therapies to patients. Register, ask questions, and find your best-fit solution for free. |
|
|
|
| My First Forty Years At DIA | Article | By Alberto Grignolo, DIA | Following the simple logical flow we recommend for all Global Forum articles—What, So What, Now What—let’s delve into why DIA remains a cornerstone for professional growth and innovation in our field. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
